Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 2
1992 3
1993 1
1994 4
1995 3
1996 4
1998 2
1999 6
2000 4
2001 2
2002 5
2003 5
2004 10
2005 3
2006 3
2007 9
2008 5
2009 5
2010 7
2011 5
2012 6
2013 6
2014 7
2015 3
2016 7
2017 7
2018 6
2019 2
2020 5
2021 6
2023 7
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

142 results

Results by year

Filters applied: . Clear all
Page 1
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer.
Glaviano A, Foo ASC, Lam HY, Yap KCH, Jacot W, Jones RH, Eng H, Nair MG, Makvandi P, Geoerger B, Kulke MH, Baird RD, Prabhu JS, Carbone D, Pecoraro C, Teh DBL, Sethi G, Cavalieri V, Lin KH, Javidi-Sharifi NR, Toska E, Davids MS, Brown JR, Diana P, Stebbing J, Fruman DA, Kumar AP. Glaviano A, et al. Among authors: fruman da. Mol Cancer. 2023 Aug 18;22(1):138. doi: 10.1186/s12943-023-01827-6. Mol Cancer. 2023. PMID: 37596643 Free PMC article. Review.
The PI3K Pathway in Human Disease.
Fruman DA, Chiu H, Hopkins BD, Bagrodia S, Cantley LC, Abraham RT. Fruman DA, et al. Cell. 2017 Aug 10;170(4):605-635. doi: 10.1016/j.cell.2017.07.029. Cell. 2017. PMID: 28802037 Free PMC article. Review.
YAP-mediated mechanotransduction tunes the macrophage inflammatory response.
Meli VS, Atcha H, Veerasubramanian PK, Nagalla RR, Luu TU, Chen EY, Guerrero-Juarez CF, Yamaga K, Pandori W, Hsieh JY, Downing TL, Fruman DA, Lodoen MB, Plikus MV, Wang W, Liu WF. Meli VS, et al. Among authors: fruman da. Sci Adv. 2020 Dec 4;6(49):eabb8471. doi: 10.1126/sciadv.abb8471. Print 2020 Dec. Sci Adv. 2020. PMID: 33277245 Free PMC article.
Phosphoinositide kinases.
Fruman DA, Meyers RE, Cantley LC. Fruman DA, et al. Annu Rev Biochem. 1998;67:481-507. doi: 10.1146/annurev.biochem.67.1.481. Annu Rev Biochem. 1998. PMID: 9759495 Review.
Targeting the Mevalonate Pathway in Cancer.
Juarez D, Fruman DA. Juarez D, et al. Among authors: fruman da. Trends Cancer. 2021 Jun;7(6):525-540. doi: 10.1016/j.trecan.2020.11.008. Epub 2021 Jan 6. Trends Cancer. 2021. PMID: 33358111 Free PMC article. Review.
Statin-induced Mitochondrial Priming Sensitizes Multiple Myeloma Cells to BCL2 and MCL-1 Inhibitors.
Juarez D, Buono R, Matulis SM, Gupta VA, Duong M, Yudiono J, Paul M, Mallya S, Diep G, Hsin P, Lu A, Suh SM, Dong VM, Roberts AW, Leverson JD, Jalaluddin M, Liu Z, Bueno OF, Boise LH, Fruman DA. Juarez D, et al. Among authors: fruman da. Cancer Res Commun. 2023 Dec 8;3(12):2497-2509. doi: 10.1158/2767-9764.CRC-23-0350. Cancer Res Commun. 2023. PMID: 37956312 Free PMC article.
Idelalisib--a PI3Kδ inhibitor for B-cell cancers.
Fruman DA, Cantley LC. Fruman DA, et al. N Engl J Med. 2014 Mar 13;370(11):1061-2. doi: 10.1056/NEJMe1400055. N Engl J Med. 2014. PMID: 24620870 Free PMC article. No abstract available.
142 results